New hope for tough lung cancers: experimental combo targets resistant tumors
Disease control
Not yet recruiting
This study tests whether adding the experimental drug plinabulin to standard chemotherapy (docetaxel) helps people with advanced non-squamous lung cancer live longer. It includes about 442 adults whose cancer has worsened despite prior immunotherapy and platinum chemo. Participan…
Phase: PHASE3 • Sponsor: BeyondSpring Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC